Analytical Biosciences
Latest round
- Series A
Last raised
- May 2021
Total raised
- Undisclosed
Investors
- 6
About Analytical Biosciences
Based in Beijing, China and established in 2018, Analytical Biosciences Limited is a single-cell genome developer which focuses on single cell sequencing and map researches, cancer genomics, bioinformatics and biological big data mining. The company has established dual operation centers in China and the United States. The company is committed to fully applying the single-cell mechanism research platform and bioinformatics big data/AI platform to the treatment and diagnosis of major human diseases such as cancer. Through the established and high-speed and continuous improvement of the single-cell accurate map of human diseases, new ones can be discovered Targets for treatment and diagnosis, and produce breakthrough therapeutic drugs. The company will further systematically expand and accelerate the company’s single-cell big data platform, single-cell one-stop data analysis platform and other transformational applications in the field of innovative drug research and development; strengthen the company’s drug target research and development center, candidate macromolecular mechanism research and development center and high performance The construction of the biological computing/AI platform enhances the company's core competitiveness in the efficient processing and in-depth interpretation of massive single-cell data. At the same time, the company will also promote the development of new drug targets, biological immunological verification, antibody development, biomarker discovery, basic scientific research and clinical research.
Who invested in Analytical Biosciences
6 investors across 3 rounds
See all investors in Analytical Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Analytical Biosciences
Who invested in Analytical Biosciences?
Analytical Biosciences has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Analytical Biosciences raised?
Analytical Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Analytical Biosciences last raise money?
Analytical Biosciences's most recent round on record is a Series A, in May 2021.
What does Analytical Biosciences do?
Based in Beijing, China and established in 2018, Analytical Biosciences Limited is a single-cell genome developer which focuses on single cell sequencing and map researches, cancer genomics, bioinformatics and biological big data mining.
Where is Analytical Biosciences headquartered?
Analytical Biosciences is headquartered in Beijing, China.
Which VCs invest in companies like Analytical Biosciences?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Analytical Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Analytical Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.